Vascular Graft Solutions

Medical Equipment Manufacturing · 11 Employees
Email Address: info@graftsolutions.com
  • Overview
  • Employees
Access 15 Verified Employees Profiles for Vascular Graft SolutionsUnlock Free Contacts Now
About
Vascular Graft Solutions (VGS), was founded in 2009 and is focusing on the development and commercialization of innovative solutions to improve the outcome of bypass surgeries. The company’s leading product, the VEST (Venous External Scaffolding Technology), is a novel external mechanical support for autologous vein grafts, intended for improving vein graft longevity. Pre-clinical and clinical studies confirmed that by restraining wall tension and improving lumen uniformity, the VEST optimizes vein graft hemodynamics and mitigates vein graft disease. Randomized controlled trials and real-world data studies in Europe, demonstrated the biomechanical effect of external stenting, its statistically significant mitigation of vein graft disease, and improved clinical outcomes.
Year Founded
2009
Social Media
Linkedin
Industry
Medical Equipment Manufacturing
HQ Location
24 Raoul Wallenberg St. Ziv Towers Building A Tel-Aviv, 6971921, IL
Keywords
Cardiac SurgeryVascular SurgeryCoronary Artery Bypass SurgeryPeripheral Artery Bypass Surgery
Location
  • 24 Raoul Wallenberg St. Ziv Towers Building A Tel-Aviv, 6971921, IL

Email Formats

Sign up for free credits and discover verified email addresses of Vascular Graft Solutions
FormatExamples
first + last
andywarhol@graftsolutions.com
first_initial + last
awarhol@graftsolutions.com
first + last_initial
andyw@graftsolutions.com
first
andy@graftsolutions.com
last
warhol@graftsolutions.com
Get Verified Emails for 15 Vascular Graft Solutions Employees

Frequently Asked Questions

Learn More about Vascular Graft Solutions

Similar Companies

Medical Equipment Manufacturing

Get key business info for Vascular Graft Solutions and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.